2m 2m 2m 2m 2m 2m 2m
Pacira BioScienc (PCRX)
NASDAQ
$26.59+$0.18 (+0.70%)
Price as of Aug 03, 2026 11:32 AM EDT- $1.0BMarket Cap
- 19.66%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Pacira BioScienc (PCRX)
$26.59+$0.18 (+0.70%)
PCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.41 | ||
Change | -$0.56 (-2.08%) | ||
Open | $26.86 | ||
High | $27.03 | ||
Low | $25.97 | ||
Previous Close | $26.97 | ||
Volume | 540,070 | ||
30-Day Average Volume | 504,305 | ||
1-Week Change | 2.05% | ||
1-Month Change | 4.10% | ||
1-Year Change | 19.66% | ||
3-Year Change | -27.35% | ||
5-Year Change | -55.20% | ||
Fundamentals | |||
Shares Outstanding | 39.3M | ||
Total Assets | $1.2B | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $177.4M | ||
Net Income | $2.9M | ||
Free Cash Flow | $23.0M | ||
EBIT | $8.7M | ||
EBITDA | $30.0M | ||
Net Working Capital | $406.2M | ||
EPS | $0.07 | ||
Enterprise Value/EBITDA | 45 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 2 | ||
P/E | 377 | ||
PEG | 4 | ||
Price/Free Cash Flow | 45 | ||
Price/Operating Cash Flow | 40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue